Rallybio Corporation (RLYB) Options Chain

The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.

Rallybio Corporation (RLYB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $77.0M, listed on NASDAQ, employing roughly 15 people, carrying a beta of -1.10 to the broader market. Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Led by Stephen Uden, public since 2021-07-29.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for RLYB as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →